Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situtations (PAIN-COnTRoLS)
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
By doing this study, researchers hope to learn about the safety and effectiveness of nortriptyline, duloxetine, pregabalin and mexiletine in treating CSPN.
Description
The purpose of this study is to determine which pharmaceutical therapy is most effective and causes the fewest side effects in cryptogenic sensory polyneuropathy.
Details
| Condition | Neuropathy |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX4790 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.